Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment

Guanfacine extended release (GXR) and atomoxetine (ATX) are nonstimulant treatments for attention-deficit/hyperactivity disorder (ADHD). As nonstimulant treatments are often used after stimulants in ADHD, GXR was assessed relative to prior stimulant treatment in a randomized controlled trial (RCT),...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuropsychiatr Dis Treat
Autors principals: Huss, Michael, Sikirica, Vanja, Hervas, Amaia, Newcorn, Jeffrey H, Harpin, Valerie, Robertson, Brigitte
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4863687/
https://ncbi.nlm.nih.gov/pubmed/27226715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S94158
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars